Impact on Patient Care

More documents

Recommendations

Info

A.R.M. Program: Escherichia coli(2000-2008)1009080706050403020100CirprofloxacinLevofloxacinNationalNENJPA14
Klebsiella pneumoniae Resistance caused by extended-spectrumcephalosporinases Related to -lactamases (TEM-1, TEM-2, SHV-1)but target 3rd generation cephalosporins National incidence: 14% (variable) Brooklyn,NY-15 hospitals. MDR incidence = 2.5%(2005)vs. 22% (2006) JAC 2007 (May 9)15
Page 1 and 2: Update on Antibacterial Resistance<
Page 3 and 4: Bad Bugs—No Drugs!2 M people will
Page 5 and 6: Major Factors Contributing to theEm
Page 7 and 8: Historical Perspective Until 1989 v
Page 9 and 10: 400 + Hospitals21% Teaching79% Comm
Page 11 and 12: Escherichia coli Leading nosocomial
Page 13: A.R.M. Program: Escherichia coli(20
Page 17 and 18: Pseudomonas aeruginosa Inducible, c
Page 19 and 20: Gram-Positive OrganismsIf We Only K
Page 21 and 22: A.R.M. Program: Staph aureus(2000-2
Page 23 and 24: Vancomycin ResistantStaphylococcus
Page 25 and 26: % macrolide resistanceRelationship
Page 27 and 28: A.R.M. Program: Enterococcus faeciu
Page 29 and 30: A.R.M. Program: Streptococcus pneum
Page 31 and 32: Preventing ResistanceUnrealistic pa
Page 33 and 34: Strategies for Overcoming Resistanc
Page 35: Changing the Paradigm: What does th
Page 45 and 46: Program InformationA.R.M. ProgramPa

Impact on Patient Care

Create successful ePaper yourself

Delete template?

Save as template?